Pure insulin highly respirable powders for inhalation

被引:28
作者
Balducci, Anna Giulia [1 ]
Cagnani, Stefano [2 ]
Sonvico, Fabio [3 ]
Rossi, Alessandra [2 ]
Barata, Pedro [4 ]
Colombo, Gaia [5 ]
Colombo, Paolo [2 ]
Buttini, Francesca [1 ]
机构
[1] Univ Parma, Biopharm TEC, Interdepartmental Ctr, I-43124 Parma, Italy
[2] Univ Parma, Dept Pharm, I-43124 Parma, Italy
[3] Univ Technol Sydney, Sch Pharm, Sydney, NSW 2007, Australia
[4] Univ Fernando Pessoa, Fac Ciencia Saude, P-4249004 Oporto, Portugal
[5] Univ Ferrara, Dept Life Sci & Biotechnol, I-44121 Ferrara, Italy
关键词
Insulin; Inhalation powder; Spray-drying; Microparticles; Excipient-free; Pulmonary drug delivery; INHALED INSULIN; NANOPARTICLES; DELIVERY; AEROSOL; EXUBERA;
D O I
10.1016/j.ejps.2013.08.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present research was to investigate the possibility to obtain by spray drying an insulin pulmonary powder respirable and stable at room temperature without the use of excipients. Several insulin spray-dried powders were prepared with or without the addition of excipients (mannitol, bovine serum albumin, aspartic acid) from water dispersions or from acidic aqueous solutions. Each formulation was characterized using laser diffraction, scanning electron microscopy and in vitro aerosol performance with a Turbospin DPI device. Stability was assessed by the quantification of impurities with a molecular mass greater than that of insulin (HMWP) and related proteins (A21 + ORP). Insulin powders prepared without excipients from an acid solution showed a shrivelled, raisin-like shape of non-aggregated microparticles and a high respirability (FPF > 65%). The optimal result with respect to respirability and stability was reached when the pH of the insulin acetic acid solution to spray dry was adjusted at pH 3.6 with ammonium hydroxide. The median volume diameter of the obtained powder was 4.04 mu m, insulin content 95%, emitted dose of 89.5%, MMAD 1.79 mu m and fine particle fraction of 83.6%. This powder was stable at room temperature over a period of eighteen months with respect to the content of A21 + ORP. As far as the HMWP content was concerned, the powder complied with the specification limits for a period of five months. The insulin acetic powder opens up the possibility of a more effective pulmonary therapy less dependent on refrigerated storage. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:110 / 117
页数:8
相关论文
共 31 条
[1]   Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations [J].
Al-Qadi, S. ;
Grenha, A. ;
Carrion-Recio, D. ;
Seijo, B. ;
Remunan-Lopez, C. .
JOURNAL OF CONTROLLED RELEASE, 2012, 157 (03) :383-390
[2]   Exubera inhaled insulin: a review [J].
Barnett, AH .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (04) :394-401
[3]   Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles [J].
Buttini, F. ;
Soltani, A. ;
Colombo, P. ;
Marriott, C. ;
Jones, S. A. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 33 (01) :20-28
[4]  
Buttini F, 2013, ULLA POSTGRAD PHARM, P91
[5]   Particles and powders: Tools of innovation for non-invasive drug administration [J].
Buttini, Francesca ;
Colombo, Paolo ;
Rossi, Alessandra ;
Sonvico, Fabio ;
Colombo, Gaia .
JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) :693-702
[6]  
Cagnani S., 2004, US Patent Number, Patent No. [7625865 B2, 7625865]
[7]   Insulin Lung Deposition and Clearance Following TechnosphereA® Insulin Inhalation Powder Administration [J].
Cassidy, James P. ;
Amin, Nikhil ;
Marino, Mark ;
Gotfried, Mark ;
Meyer, Thomas ;
Sommerer, Knut ;
Baughman, Robert A. .
PHARMACEUTICAL RESEARCH, 2011, 28 (09) :2157-2164
[8]   Methacholine dry powder inhaler as a new tool for bronchial challenge test [J].
Colombo, G. ;
Terzano, C. ;
Colombo, P. ;
Petroianni, A. ;
Ricci, A. ;
Buttini, F. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 352 (1-2) :165-171
[9]   Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration [J].
Depreter, Flore ;
Amighi, Karim .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 76 (03) :454-463
[10]  
Garcia-Contreras L, 2003, AAPS PHARMSCI, V5